Home urine C-peptide creatinine ratio testing can identify type 2 and MODY in pediatric diabetes: UCPCR in pediatric MODY, T1D, and T2D
Open accessThe DOI matches its Crossref record; 6 of the 6 references it cites were found in a registry or an index.
Abstract
BACKGROUND: Making the correct diabetes diagnosis in children is crucial for lifelong management. Type 2 diabetes and maturity onset diabetes of the young (MODY) are seen in the pediatric setting, and can be difficult to discriminate from type 1 diabetes. Postprandial urinary C-peptide creatinine ratio (UCPCR) is a non-invasive measure of endogenous insulin secretion that has not been tested as a diagnostic tool in children or in patients with diabetes duration <5 yr. We aimed to assess whether UCPCR can discriminate type 1 diabetes from MODY and type 2 in pediatric diabetes. METHODS: Two-hour postprandial UCPCR was measured in 264 patients aged <21 yr (type 1, n = 160; type 2, n = 41; and MODY, n = 63). Receiver operating characteristic curves were used to identify the optimal UCPCR cutoff for discriminating diabetes subtypes. RESULTS: UCPCR was lower in type 1 diabetes [0.05 (<0.03-0.39) nmol/mmol median (interquartile range)] than in type 2 diabetes [4.01 (2.84-5.74) nmol/mmol, p < 0.0001] and MODY [3.51 (2.37-5.32) nmol/mmol, p < 0.0001]. UCPCR was similar in type 2 diabetes and MODY (p = 0.25), so patients were combined for subsequent analyses. After 2-yr duration, UCPCR ≥ 0.7 nmol/mmol has 100% sensitivity [95% confidence interval (CI): 92-100] and 97% specificity (95% CI: 91-99) for identifying non-type 1 (MODY + type 2 diabetes) from type 1 diabetes [area under the curve (AUC) 0.997]. UCPCR was poor at discriminating MODY from type 2 diabetes (AUC 0.57). CONCLUSIONS: UCPCR testing can be used in diabetes duration greater than 2 yr to identify pediatric patients with non-type 1 diabetes. UCPCR testing is a practical non-invasive method for use in the pediatric outpatient setting.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Maturity-onset diabetes of the young (MODY): how many cases are we missing?
Shields, B. M., Hicks, S., Shepherd, M. H., Colclough, K., Hattersley, A. T., & Ellard, S. (2010) · Diabetologia · doi:10.1007/s00125-010-1799-4 · Cited by 725
Self-citationPalmer, J. P., Fleming, G. A., Greenbaum, C. J., Herold, K. C., Jansa, L. D., Kolb, H., Lachin, J. M., Polonsky, K. S., Pozzilli, P., Skyler, J. S., et al. (2004) · Diabetes · doi:10.2337/diabetes.53.1.250 · Cited by 491
Effect of Metformin in Pediatric Patients With Type 2 Diabetes
Jones, K. L., Arslanian, S., Peterokova, V. A., Park, J.-S., & Tomlinson, M. J. (2002) · Diabetes Care · doi:10.2337/diacare.25.1.89 · Cited by 392
Rising Incidence of Type 2 Diabetes in Children in the U.K.
Haines, L., Wan, K. C., Lynn, R., Barrett, T. G., & Shield, J. P. H. (2007) · Diabetes Care · doi:10.2337/dc06-1813 · Cited by 258
Self-citationMcDonald, T. J., Knight, B. A., Shields, B. M., Bowman, P., Salzmann, M. B., & Hattersley, A. T. (2009) · Clinical Chemistry · doi:10.1373/clinchem.2009.129312 · Cited by 75 · cited 2×
“directly to the Biochemistry department at the Royal Devon & Exeter National Health Service Foundation Trust, Exeter, UK, to allow analysis within 72 h of sample collection, according to assay stability (20).”
MethodSelf-citationBowman, P., McDonald, T. J., Shields, B. M., Knight, B. A., & Hattersley, A. T. (2012) · Diabetic Medicine · doi:10.1111/j.1464-5491.2011.03428.x · Cited by 40
Self-citation
Cited by
Oram, R. A., Patel, K., Hill, A., Shields, B., McDonald, T. J., Jones, A., Hattersley, A. T., & Weedon, M. N. (2016) · Diabetes Care · doi:10.2337/dc15-1111 · Cited by 349
Self-citationPainting a new picture of personalised medicine for diabetes
McCarthy, M. I. (2017) · Diabetologia · doi:10.1007/s00125-017-4210-x · Cited by 255
Shepherd, M., Shields, B., Hammersley, S., Hudson, M., McDonald, T. J., Colclough, K., Oram, R. A., Knight, B., Hyde, C., Cox, J., et al. (2016) · Diabetes Care · doi:10.2337/dc16-0645 · Cited by 236
“We subjected only those patients who had significant endogenous insulin (C-peptide) levels and did not have autoantibodies to systematic genetic testing, although previous research (14,17,18) and our failure to find anymutations in 65 patients who did have significant C-peptide levels but were antibody positive suppor…”
BackgroundSelf-citationMaturity-onset diabetes of the young (MODY): an update
Anık, A., Çatlı, G., Abacı, A., & Böber, E. (2015) · Journal of Pediatric Endocrinology and Metabolism · doi:10.1515/jpem-2014-0384 · Cited by 198
Shields, B. M., Shepherd, M., Hudson, M., McDonald, T. J., Colclough, K., Peters, J., Knight, B., Hyde, C., Ellard, S., Pearson, E. R., et al. (2017) · Diabetes Care · doi:10.2337/dc17-0224 · Cited by 151
Self-citation
Metadata
- Authors
- Besser, R. E., Shields, B. M., Hammersley, S. E., Colclough, K., McDonald, T. J., Gray, Z., Heywood, J. J., Barrett, T. G., & Hattersley, A. T.
- Venue
- Pediatric Diabetes
- Publisher
- Hindawi Limited
- Published
- 2012-12
- Volume
- 14
- Issue
- 3
- Pages
- n/a-n/a
- ISSN
- 1399-543X (ISSN-L)
- OpenAlex
- W2156696375
- Cited by
- 36
- References
- 6
- FWCI
- 1.06
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Home urine C-peptide creatinine ratio testing can identify type 2 and MODY in pediatric diabetes: UCPCR in pediatric MODY, T1D, and T2D. https://app.cochat.ai/papers/10.1111/pedi.12008
- The paper
- Besser, R. E., Shields, B. M., Hammersley, S. E., Colclough, K., McDonald, T. J., Gray, Z., Heywood, J. J., Barrett, T. G., & Hattersley, A. T. (2012). Home urine C-peptide creatinine ratio testing can identify type 2 and MODY in pediatric diabetes: UCPCR in pediatric MODY, T1D, and T2D. Pediatric Diabetes. https://doi.org/10.1111/pedi.12008
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.